SCHEMBL14284886

SCHEMBL14284886

COC(=O)[C@H]1C[C@@]2(CCC(=O)O2)C2(C)C[C@H](O)C3C(CCC4=CC(=O)CCC43C)C12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 8/20 0.52
▸ LMNA P02545 4/20 0.52
▸ NR3C2 P08235 8/20 0.51
▸ PGR P06401 6/20 0.51
▸ NR3C1 P04150 5/20 0.51
▸ AR P10275 4/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ SERPINA6 P08185 3/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ SHBG P04278 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ NFKB1 P19838 2/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ CHRM1 P11229 2/20 0.49
▸ HSD11B1 P28845 2/20 0.48
▸ HSD11B2 P80365 2/20 0.48
▸ BLM P54132 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14308729 0.86 HIF1A (0.54) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14285044 0.81 HIF1A (0.66) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14568530 0.81 HIF1A (0.66) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14508986 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14565704 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14450055 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14567743 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14084961 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL31277081 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1
SCHEMBL14567820 0.79 NR3C1 (0.70) HIF1ALMNANR3C2PGRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein NG JOHN S 2008-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein CYP4A11, CYP11B1, CYP17A1 HIF1A 2302/4885LMNA 1449/4885NR3C2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback